logo
Stop making this handwashing mistake, eat shrimp and use the Pomodoro technique to clean up — plus 8 more tips to improve your health

Stop making this handwashing mistake, eat shrimp and use the Pomodoro technique to clean up — plus 8 more tips to improve your health

Yahoo09-05-2025
Hello Yahoo Life readers! My name is Kaitlin Reilly, and I am here to share the best health and wellness tips from around the internet.
This week, Kerry Justich spoke to American track and field Olympian Gabby Thomas, who spilled her wellness routine. This includes drinking coffee, which Thomas says is 'one of the first things I do every morning.'
The athlete may not be ditching coffee anytime soon, but plenty of people are, whether that's due to caffeine jitters or digestive woes. The good news? There are some excellent coffee alternatives on the market.
This week, I explored whether beanless brews and coffee blends — some of which are made with mushrooms or upcycled ingredients like date pits — are a good solution for when you're craving a pick-me-up that isn't a traditional cup of joe. While experts say there's no reason to ditch coffee if your body responds well to it, you could get some perks by sipping on these beverages, such as a brain boost from adaptogens like reishi.
Take a peek at the local weather forecast and, if so inclined, peruse your horoscope to see what the stars have in store. Then check out what small steps you can take to make the week ahead great.
The National Foundation for Infectious Diseases just released its State of Handwashing report, which revealed that 48% of Americans are not washing their hands at key times. But some may not be aware of what those times even are. For example, while most Americans sudsed up after going to the bathroom and handling food (phew!), the NFID says that we should also be washing our hands after visiting food-centric places — like a grocery store, restaurant or coffee shop — as well as the doctor's office, pharmacy or hospital. These places have the potential to be particularly germy, and those germs can go from your hands into your mouth, eyes or nose and get you sick.
An easy habit to stick with? Wash your hands every time you come home, and make sure you're doing it the right way: Scrub with soap and water for at least 20 seconds, making sure to get under your fingernails. Don't forget to properly dry your hands too; wet hands spread germs more easily.
May 10 is National Shrimp Day, but there are a lot of reasons to eat this crustacean year-round. One big benefit of shrimp is that it's very low in calories while also being high in protein — a three-ounce serving has about 20 grams of protein. Plus, it also contains minerals like potassium, phosphorus and magnesium.
Want to get the best-tasting shrimp? While it may make dinner take a little longer to prepare due to the de-shelling process, buying shrimp that are still in their shells will deepen that umami flavor.
It's already May, and you still haven't gotten around to spring cleaning? It's time to stop procrastinating. Yes, organizing your closets and filing 6 months' worth of random paperwork can feel overwhelming, but Apartment Therapy has a handy hack: Try cleaning with the Pomodoro technique, a method in which you work in focused 25-minute intervals followed by five-minute breaks. The goal? Staying motivated while also breaking down big tasks into smaller, more manageable chunks. Your house will get clean and you won't lose your mind in the process — a win-win!
Weird … but kind of genius? A writer at Salon found that her smoothies tasted even better when she started using roasted fruit. Think roasting peaches with honey and cinnamon, or creating an apple pie-inspired smoothie by baking apples, storing them in the fridge overnight and then blending them with rolled oats in the a.m. It's a great way to make a morning smoothie way more exciting with new flavors.
The latest fitness craze on social media? People doing 100 kettlebell swings a day. You don't need to do that many reps to enjoy the benefits of this exercise, however.
'Most of us spend a lot of time sitting — on our phones, at our computers, in our cars — which makes the front of our body super-tight and pulls us into that rounded, hunchback position,' personal trainer Nico Gonzalez tells Yahoo Life. 'When done correctly, kettlebell swings really activate the muscles along your spine, the backs of your arms and the backs of your legs, which helps bring your posture upright. So, it's actually a really great corrective exercise.'
Research says that working out with kettlebells can improve your grip and muscle strength overall, as well as lower inflammation. This week, make your gym workout all about kettlebells with this five-move kettlebell plan.
I recently hit up an infrared sauna on my longevity treatment journey and was so glad I did; there's nothing more relaxing than getting a good sweat in. But there's science behind the sweat too: Regularly using a sauna has been shown to reduce joint and muscle stiffness, improve your immune system and enhance sleep. Plus, spending time in a sauna has also been linked to a better mood. I, for one, am never happier.
Try sitting in a sauna for 15 to 20 minutes, Dr. Jaclyn Tolentino, a primary care physician at Love.Life, tells Women's Health. If you feel dizzy or sick, step out. "Sauna use should feel like a supportive ritual, not a challenge to power through,' Tolentino explains. "The key is to listen to your body — it should feel nourishing, not punishing."
Gossiping has an admittedly bad reputation. But there's actually some good that can come from talking about others. 'Human connection through shared information and communication is core to who we are and connects us to each other,' Thea Gallagher, director of wellness programs at NYU Langone Health, tells Fox News. 'We might feel closer to someone when we know they are confiding in us with information and vice versa.'
And gossiping can also build empathy. For example, if you get wind that someone else is dealing with something (divorce, a sick parent, etc.) you can relate to, you may feel more connected to that person and be even more likely to open up to them in the future.
The key to making sure gossip never becomes malicious or catty is to ensure it's coming from a place of curiosity, rather than to harm someone's reputation through the spread of mean-spirited comments.
May 11 is National Foam Rolling Day, which should be your reminder to break out your roller after an intense exercise session. Foam rolling is a practice in which you use a foam cylinder (or sometimes even something spherical, like a hard rubber ball) to apply pressure to sore or tight muscles. This targets fascia, aka the connective tissue surrounding muscles and organs. It helps increase blood flow, reduce muscle tension and improve flexibility, making it an excellent way to aid in recovery, not to mention prevent injury next time you work out.
Need help getting started? Try these two easy exercises from Men's Fitness. And make sure to skip foam rolling your neck, joint areas or anywhere that you're already injured; you could do more harm than good.
In the mood to try a new tea? Try dandelion tea — especially if you deal with digestive discomfort. Dandelion tea can help relieve bloating, which can potentially come from eating a high-sodium diet, thanks to its natural diuretic properties, helping to flush excess fluid from the body.
But that's not the only reason to try this herbal tea: Dandelion tea is packed with antioxidants, including beta-carotene, in addition to being a good source of vitamin A.
You may have seen the 'okra water' trend making its rounds on TikTok, with some claiming that this drink — which is made by soaking sliced raw okra pods overnight and straining out the solids — helps with blood sugar control. While there haven't been studies confirming this, there is still a good reason to eat okra, which is packed with fiber, minerals and antioxidants. It's specifically a great source of magnesium and folate, which support muscle and heart health. Try pickling it, using shorter pods and patting them dry before brining to avoid a slimy texture.
Resistance training is so important for maintaining muscle mass and bone health. This week, change things up by picking up a medicine ball. Training with a medicine ball helps build 'explosive power, increases body strength, increases speed and provides more versatile movement in different planes,' fitness coach Tatiana Lampa tells Women's Health.
You can slam a medicine ball, toss it or twist with it beyond what you could do with a traditional weight. Plus, the shape and feel of a medicine ball means it mimics real-world activities — like, say, lifting a toddler or carrying a bag of groceries — which helps build functional strength.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Advanced Ophthalmology Technology Market to Hit Valuation of US$ 16.01 Billion by 2033
Advanced Ophthalmology Technology Market to Hit Valuation of US$ 16.01 Billion by 2033

Yahoo

time12 minutes ago

  • Yahoo

Advanced Ophthalmology Technology Market to Hit Valuation of US$ 16.01 Billion by 2033

The market is rapidly advancing, driven by an aging population's needs. A clear segmentation is emerging hospitals focus on complex, high-margin procedures, while specialized centers increasingly absorb routine surgeries. Chicago, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is expected to reach US$ 16.01 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025–2033. The future of the advanced ophthalmology technology market is being written today in research labs and clinical trials around the world. A robust pipeline of innovative treatments, particularly in areas like gene therapy for inherited and chronic eye diseases, holds the promise of not just managing but potentially reversing vision loss. The intense research activity is also reflected in the continuous stream of new patents being filed, protecting the intellectual property that will form the basis of next-generation devices and therapies. This forward-looking activity, combined with a growing and specialized workforce, ensures a long-term trajectory of growth and transformative breakthroughs for the industry. Download Sample Pages: The scale of innovation is evident in patent and clinical trial data. In 2024 alone, 1,393 international patents related to vision science were published. Ophthalmic Sciences, an innovator in the field, holds 6 total patents, with 3 of those being active globally. The clinical trial landscape is equally vibrant. The RGX-314 gene therapy trial for wet AMD has enrolled 465 patients, while the SOL-R registrational trial for AXPAXLI in the same condition has a target randomization of at least 555 patients. A search on reveals 22 active clinical studies focused on gene therapy for wet AMD. Supporting this innovation is a skilled workforce; the mean number of ophthalmologists per 100,000 inhabitants across Europe is 9.36, with nations like Italy having 12.28 practicing ophthalmology physicians per 100,000 persons in 2024. Niche markets are also showing strong growth, with the U.S. dry eye treatment devices market reaching approximately $99.7 million in 2024 to serve the around 16 million people diagnosed with Dry Eye Disease. Key Findings in Advanced Ophthalmology Technology Market Market Forecast (2033) US$ 16.01 billion CAGR 6.9% Largest Region (2024) North America (39%) By Type Diagnostic (58%) By End Use Hospitals (41%) Top Drivers Rising prevalence of age-related eye diseases boosts technology demand. Continuous technological advancements are improving diagnostic and surgical outcomes. Growing patient awareness regarding the importance of early eye diagnosis. Top Trends Artificial intelligence integration is revolutionizing diagnostics and treatment planning. Increasing surgeon and patient preference for minimally invasive procedures. Shift of routine surgeries from hospitals to specialized outpatient centers. Top Challenges The high acquisition and maintenance costs of advanced ophthalmic technologies. A growing shortage of skilled ophthalmologists to operate new equipment. Complex reimbursement policies and stringent regulatory approval processes. Financial Titans Dominating the Global Advanced Ophthalmology Technology Market Landscape The financial health of key industry players provides a powerful indicator of the market's robust vitality and sustained growth potential. These leading companies are demonstrating exceptional performance through impressive sales figures and strong operational cash flows, reflecting the high demand for their innovative products. Their financial strength not only solidifies their market position but also enables continued investment in the research and development that drives the entire sector forward. A close examination of their financial reports reveals a clear and compelling narrative of a thriving and profitable industry, setting a confident tone for future expansion and shareholder value in a competitive environment. Alcon, a global leader in the advanced ophthalmology technology market, showcases remarkable financial strength, reporting total net sales of $9.8 billion for the full year 2024. The performance was robust across its divisions, with Surgical net sales reaching $5.5 billion and Vision Care net sales hitting $4.3 billion. The company achieved a record cash from operations of $2.1 billion and a record free cash flow of $1.6 billion. A breakdown of 2024 quarterly performance further illustrates this momentum: Q1 sales were $2.4 billion, with $341 million in cash from operations and $229 million in free cash flow. Q2 sales increased to $2.5 billion, with Surgical net sales at $1.4 billion and Vision Care sales reaching $2.2 billion in the first half. Q3 saw net sales of $2.4 billion, with the Surgical segment contributing $1.34 billion, and Q4 sales were $2.5 billion. Bausch + Lomb also posted strong full-year 2024 revenues of $4.791 billion, with its Surgical segment accounting for $843 million and generating $232 million in cash flow from operations for the year. The company's third quarter revenue was $1.196 billion, with the surgical segment at $206 million and cash flow from operations at $154 million, while Q4 surgical revenue was $231 million. Topcon's Eye Care business reported first-half fiscal year 2024 sales of ¥37.1 billion (€224 million), with a full-year revenue forecast of ¥82.0 billion (€495 million). The combined North American and European half-year sales for Topcon were approximately ¥60 billion, underscoring the strong international demand within the advanced ophthalmology technology market. Unprecedented Surgical Volumes Propel Growth in the Advanced Ophthalmology Technology Market The sheer volume of surgical procedures performed worldwide is a primary engine powering the expansion of the market. An aging global population and the increased prevalence of conditions like cataracts are driving millions of patients to seek surgical solutions. Simultaneously, the introduction of safer, faster, and more effective minimally invasive techniques has broadened patient acceptance and accessibility. The statistics on cataract, LASIK, and SMILE procedures paint a vivid picture of a sector experiencing immense procedural demand. Such high volumes necessitate a continuous supply of advanced surgical equipment, implants, and consumables, creating a powerful and self-reinforcing cycle of growth and innovation. By 2025, an estimated 28 million cataract surgeries are performed annually across the globe, which translates to roughly 75,000 procedures every single day. The minimally invasive refractive procedure, Small Incision Lenticule Extraction (SMILE), has already surpassed 10 million procedures performed worldwide as of the end of 2024 in the advanced ophthalmology technology market. Since its FDA approval in 2016, an average of more than 1 million people have chosen SMILE each year, a procedure now offered by over 2,000 surgeons in 70 countries. The demand for intraocular lenses (IOLs) is staggering, with a projected 200 million patients requiring IOL implantation by 2025. In the United States alone, approximately 800,000 LASIK procedures are performed annually. Growth is also pronounced in developing markets; the estimated cataract surgery rate in China is expected to reach 350 per 100,000 people by 2025. Illustrating global outreach efforts, one specific aid project in Cambodia has already provided free surgery to 3,138 cataract patients, highlighting the vast unmet need that technology can address. Next-Generation Diagnostic and Monitoring Tools Redefine Patient Care and Market Demand Early and accurate diagnosis is the cornerstone of effective ophthalmology, and advanced diagnostic equipment is at the forefront of advanced ophthalmology technology market. Technologies like Optical Coherence Tomography (OCT) have become indispensable, providing high-resolution, cross-sectional images of the retina that enable the detection and management of numerous sight-threatening diseases. The growing prevalence of conditions such as diabetic retinopathy and age-related macular degeneration (AMD) is directly fueling the demand for these sophisticated diagnostic platforms. The market is responding with increasingly powerful and user-friendly devices, including handheld and automated units, that are expanding access to high-quality care from specialized clinics to primary care settings. The adoption rate of these technologies is reflected in strong sales figures, with 18,700 handheld OCT units sold globally in 2023. The clinical utility is immense, with over 50 million diabetes-related OCT scans performed annually. The technology's application in the advanced ophthalmology technology market is even extending beyond human medicine, with over 500 veterinary OCT devices now in use for animal diagnostics. Industry leader Topcon has sold over 20,000 units of its Maestro OCT system globally as of late 2023, a testament to the device's popularity and reliability. The urgency for such advanced diagnostic capability is underscored by daunting projections; approximately 200 million individuals are expected to be affected by AMD by the year 2040, creating a massive patient population in need of vigilant monitoring. Premium Intraocular Lenses Signal a Paradigm Shift in Cataract Surgery Outcomes The intraocular lens (IOL) segment has evolved far beyond simple vision correction, entering an era of premium technology that offers patients a range of lifestyle-enhancing benefits. Today's advanced IOLs can correct presbyopia, astigmatism, and other refractive errors, often reducing or eliminating a patient's dependence on glasses after cataract surgery. This shift towards premium, high-performance lenses represents a significant value-add in the cataract surgery space, driving revenue growth and patient satisfaction. As patient expectations rise, so does the demand for technologies that deliver superior visual outcomes, making the premium IOL sector a key growth area within the advanced ophthalmology technology market. The market's scale is substantial, with annual IOL lens unit shipments reaching 42 million in 2023, corresponding with the roughly 25 million cataract surgeries performed that year. The procedural efficiency in modern clinics further fuels this demand. High-volume cataract clinics now see surgeons implanting an average of 1,200 lenses per year. At an institutional level, surgical centers are now performing an average of 4,500 cataract cases annually. These high procedural volumes, combined with the increasing adoption of premium IOL technologies, create a powerful economic engine that supports ongoing innovation in lens design, materials, and functionality. Robust Investment and Venture Capital Fueling Future Ophthalmic Technology Market Breakthroughs A vibrant ecosystem of investment is crucial for nurturing the next wave of innovation, and the ophthalmology sector is attracting significant capital from diverse sources. Major corporations in the advanced ophthalmology technology market are channeling billions into research and development, while a dynamic venture capital landscape is providing essential funding for startups and emerging technologies. This influx of capital is accelerating the development of groundbreaking therapies, more advanced surgical devices, and sophisticated software platforms. The high level of merger and acquisition activity further signals a mature and attractive market where proven innovations are being rapidly integrated into larger commercial platforms, promising a future rich with transformative solutions. The financial commitment to innovation is clear. Alcon's R&D investment for the twelve months ending March 31, 2025, stood at an impressive $899 million, with annual R&D expenses for 2024 totaling $876 million. Across the industry, total investment in ophthalmology in 2024 exceeded $6.3 billion. The market also saw 18 merger and acquisition transactions in 2024, indicating strong consolidation and strategic growth activity. The venture capital pipeline is equally robust, with financing in ophthalmology for the first quarter of 2025 reaching $515.7 million across 21 transactions. As of May 2025, U.S. ophthalmology companies had already raised $597 million in equity funding through 15 rounds. Looking at a longer trend, the total venture capital investment in the ophthalmic devices sector over the last 10 years has amounted to a formidable $2.51 billion. Artificial Intelligence Integration Revolutionizes Diagnostics in the Advanced Ophthalmology Technology Market Artificial intelligence (AI) is rapidly transitioning from a theoretical concept to a practical and powerful clinical tool within the market. AI algorithms are now capable of analyzing retinal images with remarkable speed and accuracy, detecting early signs of diseases like diabetic retinopathy long before they might be caught by traditional methods. This technology is democratizing access to specialist-level diagnostics, enabling screening to be performed in primary care settings and reducing the burden on ophthalmologists. The efficiency and precision of AI are not just improving patient outcomes but also creating new operational efficiencies for healthcare systems. The real-world adoption of AI is accelerating in the advanced ophthalmology technology market. As of mid-2024, 198 AI-equipped cameras have been deployed across five U.S. health systems, covering a population of approximately 151,000 patients with diabetes. In the United States, three FDA-approved AI algorithms for diabetic retinopathy screening were available as of 2025. The clinical uptake is evident in reimbursement data, with more than 15,000 Medicare claims filed for AI diabetic retinopathy screening algorithms since 2022. The efficacy of these systems was proven in a clinical trial involving 900 patients, which led to FDA approval for one AI eye exam system. The speed of these platforms is a key advantage; scans using the AEYE-DS diabetic retinopathy algorithm are designed to produce actionable results in under 60 seconds. Surgical Laser Precision and Speed Setting New Benchmarks for Ophthalmic Procedures Modern excimer and femtosecond lasers are the technological cornerstones of refractive and cataract surgery, and continuous innovation is pushing the boundaries of what is possible in the advanced ophthalmology technology market. Today's surgical laser platforms offer unparalleled precision, speed, and safety, enabling surgeons to perform highly customized and predictable procedures. Advancements in eye-tracking technology, laser pulse frequency, and treatment algorithms are leading to better visual outcomes, faster recovery times, and an enhanced patient experience. These technological leaps are critical for meeting the high expectations of patients seeking freedom from corrective eyewear and are a major factor in the continued growth of the refractive surgery market. The Bausch + Lomb TENEO Excimer Laser Platform exemplifies this cutting-edge technology with its impressive performance metrics. The platform boasts an exceptionally fast ablation time of approximately 1.2 seconds per diopter, minimizing procedure time and improving patient comfort. Supporting this speed is an advanced eye-tracker that operates at an incredible 1,740 Hz, ensuring the laser remains perfectly centered on the eye even with involuntary movements. The TENEO laser itself operates at a high speed of 500 Hz, allowing for swift and highly precise corneal tissue ablation. These specific, quantifiable advancements are what define the leading edge of the advanced ophthalmology technology market, delivering tangible benefits to both surgeons and patients. Customize the Data Scope to Match Your Objectives: Strategic Private Equity Investment and Remote Care Reshape Ophthalmic Service Delivery The business landscape of ophthalmology is being actively reshaped by two powerful forces: strategic investment from private equity and the rise of remote care models. Private equity firms are increasingly drawn to the sector's stable growth and opportunities for consolidation, leading to a wave of practice acquisitions. This trend is creating larger, more efficient practice groups with greater resources for technology adoption. In parallel, tele-ophthalmology platforms are gaining traction, leveraging technology to conduct remote eye exams and consultations. This remote care model is expanding access to services, particularly in underserved areas, and creating new, flexible models for delivering eye care. The impact of private equity is significant in the advanced ophthalmology technology market, with over 330 private equity-backed physician practice management (PPM) transactions recorded in ophthalmology over the last five years. This consolidation trend is fundamentally changing the structure of service delivery in the market. Simultaneously, the telehealth revolution is making its mark. The remote examination platform from DigitalOptometrics, for instance, has already conducted over 2 million remote exams. This number highlights a clear and growing acceptance of remote technologies by both patients and providers, signaling a permanent shift in how ophthalmic services can be delivered and scaled. Global Advanced Ophthalmology Technology Market Major Players: Alcon Allergan Bausch + Lomb Carl Zeiss Meditec EssilorLuxottica Heidelberg Engineering HOYA Johnson Johnson Vision NIDEK CO., LTD Novartis Ophthotech Corporation Regeneron Pharmaceuticals, Inc. Roche Samsung Topcon Other Prominent Players Key Market Segmentation: By Type Diagnostic Therapeutic By End Use Hospitals Ambulatory Surgical Centers (ASCs) Ophthalmic Clinics Others By Region North America Europe Asia Pacific Middle East & Africa South America Explore the Report Before You Buy – Book a Walkthrough: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Novo Nordisk, Eli Lilly rise after Viking obesity trial data

Yahoo

time12 minutes ago

  • Yahoo

Novo Nordisk, Eli Lilly rise after Viking obesity trial data

-- Novo Nordisk and Eli Lilly (NYSE:LLY) shares edged higher Tuesday following results from Viking Therapeutics' Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo Nordisk (NYSE:NVO) rose 1.4% premarket, while Eli Lilly gained 1.2%. Viking Therapeutics (NASDAQ:VKTX) plunged over 30% in premarket trading. The trial tested Viking's oral tablet VK2735, a dual GLP-1 and GIP receptor agonist, and met its primary endpoint, with patients losing up to 12.2% of body weight after 13 weeks versus 1.3% for placebo. However, a 28% treatment discontinuation rate among VK2735 recipients raised concerns, compared with 18% in the placebo group. Viking said 99% of gastrointestinal-related adverse events were mild or moderate, and an exploratory maintenance dosing arm indicated weight loss could be maintained at lower doses. Mizuho analyst Jared Holz said the data highlighted challenges relative to Eli Lilly's offerings. 'Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range — but over 72-weeks; a much longer trial, and therefore LLY looks far better head-to-head,' Holz wrote. He added that Viking would likely need pipeline improvements or enhanced formulations to regain investor interest. 'A tough day for retail investors ahead – that have been pumping this thing like a 1991 Reebok Dee Brown," concluded Holz. The results underscore the competitive pressure in the oral obesity market. Related articles Novo Nordisk, Eli Lilly rise after Viking obesity trial data Viking Therapeutics stock falls 37% on high dropout rate in obesity trial Tesla robotaxi trial impresses, pricing power clear: William Blair Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store